NCT05806203View on ClinicalTrials.gov

A Study of Participants Ages 21-65 Diagnosed With Dyspareunia and the Effects of Low Intensity Shockwave Treatment

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

April 30, 2024

Conditions
Female Dyspareunia
Interventions
DEVICE

Low intensity shockwave treatment to pelvic floor region plus typical physical therapy

Treatment dose: 1,000 - 1,500 shocks, 2.5-3.0 Hz, 0.06-0.10 mJ/mm2 (Intensity of 6-8), 8 to 12 minutes

DEVICE

Sham shockwave treatment plus typical physical therapy

Inactive dose of shockwave treatment

Trial Locations (1)

53226

RECRUITING

New You Health and Wellness, Wauwatosa

All Listed Sponsors
lead

SoftWave Tissue Regeneration Technologies

INDUSTRY